2023 Agenda

Thursday, October 5



7:00 am –  Villard Foyer

Registration & Morning Coffee

8:25 am –  Villard Ballroom

Welcome Back
Sara Jane Demy, Founder & CEO, Demy-Colton

8:30 am – Villard Ballroom

Opening “Big Think” Plenary Session
Supercharging Therapeutic Development:
Next-Gen Technology & Therapeutic Innovation that You’ve Never Heard Of

Querida Anderson, Editorial Director & Biopharma Expert

Vincent Beltrani, PhD, Enterprise Customer Engineer: Healthcare, Life Sciences and Quantum AI, Google
Eric Elenko, PhD, Chief Innovation & Strategy Officer, PureTech
Walter Greenleaf, PhD, Distinguished Visiting Scholar, MediaX, Stanford University
Susan Lenderts, General Manager, US Life Sciences, SAS

9:30 am – Holmes I

Dialogue 1A
Molding the Mind:
Pushing the Boundaries of Neuroscience with Brain Plasticity

Caroline Montojo, PhD, President & CEO, Dana Foundation

Ryan Field, CEO, Kernel 
Kurt Haggstrom, Chief Commercial Officer, Synchron
Beth Rogozinski, CEO, Oncoustics
Brent Vaughan, CEO, Cognito Therapeutics

9:30 am – Holmes II

Dialogue 1B
Alternative Financing:
Options for Life Science Companies During a Market Downturn

Kate Walsh, Managing Director, HSBC Innovation Banking

Shaun Bagai, CEO, RenovoRx
Daniella Kranjac, Founding General Partner, Dynamk Capital
Art Pappas, CEO & Managing General Partner, Pappas Capital
Brad Sitko, Chief Investment Officer, XOMA

9:30 am – 12:30 pm


10:15 am
Adams/Kennedy I/Kennedy II

Presenting Companies

11:45 am – Holmes I

Dialogue 2A
Stopping Age-Related Disease at the Cellular Level

Hilary Brueck, Correspondent, Insider

Jenna Brager, PhD, Executive VP, Drug Development, MyMD Pharmaceuticals
Daniel Oliver, Rejuvenate Bio
Thomas Seoh, Executive Vice President, Kitalys Institute
Ali Siam, CBO, Rubedo Life Sciences
Sourav Sinha, General Partner & Head of Strategy, Longevity Vision Fund

11:45 am – Holmes II

Dialogue 2B
New Diagnostics:
AI-Enabled to Reveal Disease Trajectory & Suggest Optimal Treatment

Zegbeh Jallah, PhD, Managing Director, Head of Biotech Equity Research, Capital One

Dusty Majumdar, PhD, CEO, PredxBio
Beth Rogozinski, CEO, Oncoustics
Ajit Singh, PhD, Partner, Artiman Ventures

11:45 am – Kennedy I 

Dialogue 2C
Clinical Trials:
Unleashing AI to Streamline the Process, Saving Time & Money

Susan Rosenthal, Senior Vice President, Life Sciences and Healthcare, New York City Economic Development Corporation

Seth Flaum, Partner, Wilson Sonsini
Kwame Okrah, PhD, Director, Artificial Intelligence & Machine Learning, Sanavia Oncology
Angela Radcliffe, Founder, How Mighty We Ventures
John Wagner, MD, PhD, Chief Medical Officer, Koneksa

12:30 pm – Villard Ballroom

“Big Think" Lunch Plenary
The Shifting Regulatory Landscape:
What Does It All Mean?

The IRA, FTC, Scott-Hart-Rodino, and the TRIPS Waiver are all challenges for industry. What solutions are attainable?

David Ewing Duncan, Journalist, Author, Researcher

Jennifer Hawks Bland, CEO, NewYorkBio 
Nouhad Husseini, SVP, Business Development & Corporate Strategy, Regeneron Pharmaceuticals
Dennis Purcell, Founder, Aisling Capital
Nick Shipley, Executive Vice President, BIO 

2:00 pm
Adams/Kennedy I/Kennedy II

Presenting Companies

2:00 pm – 4:45 pm


3:00 pm – Holmes I

Dialogue 3A
Rewriting the Code:
Navigating the Frontier of Gene & Cell Therapy 

Lei Lei Wu, Reporter, Endpoints News

Sean Ainsworth, CEO, Immusoft
Greg Kunst, CEO, Aurion Biotech
Christine Silverstein, CFO, Excision BioTheraputics 
Elizabeth Wood, PhD, Founder & CEO, JURA Bio

3:00 pm – Holmes II

Dialogue 3B
Venturing into the Future:
Exploring Novel Investment Frontiers 

Derek Brand, Executive Director, Strategic Partnerships, Columbia University

Anna Barry, PhD, Venture Partner, Deerfield
Nessan Bermingham, PhD, Operating Partner, Khosla Ventures
Nate Chang, Operating Partner, Playground Global
Jakob Dupont, MD, Executive Partner, Private Equity, Sofinnova Investments

3:00 pm – Kennedy I

Dialogue 3C
Clinical Virtual Reality:
Revolutionizing Next Generation Assessments & Care

Walter Greenleaf, PhD, Distinguished Visiting Scholar, mediaX – Stanford University

JoAnn Difede, PhD, Professor of Psychology, Weill Cornell Medicine
Mark Edwards, CEO & Co-Founder, ViewMind
Georgia Mitsi, PhD, Entrepreneur in Residence, Emerald BioVentures

3:45 pm

Presenting Companies

4:45 pm – Villard Ballroom

End of Day “Big Think" Plenary Session
The Lake Nona Project:
Learnings From a Purpose-Built Experi
mental Community for Health and Wellness
What started as a 17 square mile cow pasture in Orlando has grown into the world’s first purpose-built community centered around health, wellness, and innovation. This session will explore learnings from the development of Lake Nona, and how resetting the thinking around healthcare through intentional community design can drive better mental and physical health outcomes for residents.

Jeremy Abbate, VP & Publisher, Scientific American

Gloria Caulfield, Vice President, Strategic Alliances, Tavistock Development Company
Timothy Cooke, Medical Center Director/CEO, Orlando VA Healthcare System (VAHCS)

6:30 pm – 345 Park Avenue South

Reception @ Cure

Be a part of BioFuture

© 2024 BioFutureTM. All Rights Reserved

Produced by